Literature DB >> 27758995

Pulmonary stenting for the treatment of sarcoid induced pulmonary vascular stenosis.

Jose F Condado1, Vasilis Babaliaros, Travis S Henry, Brian Kaebnick, Dennis Kim, Gerald W Staton.   

Abstract

BACKGROUND: The best treatment of patients with external pulmonary vascular compression due to advanced sarcoidosis is unknown.
OBJECTIVES: To report a single-center experience of percutaneous treatment for pulmonary vascular stenosis caused by external compression due to advanced sarcoidosis.
METHODS: We report a case series of 5 patients with biopsy confirmed advanced sarcoidosis, seen at our academic institution with worsening dyspnea despite increase of immunosuppressive therapy. All patients were evaluated by a multidisciplinary team (cardiology, pulmonary and radiology) using a multi-modality approach, including chest-computed tomography angiography, ventilation/perfusion scintigraphy, pulmonary function test, 6-minute walk test and heart catheterization.
RESULTS: Three out of five patients underwent pulmonary artery or vein angioplasty and stenting resulting in symptomatic improvement: Patient 1 had persistent symptomatic improvement measured by subjective and objective methods at 30 months; patient 2 required re-intervention due to recurrent pulmonary vein stenosis at 6-months followed by persistent improvement; and patient 3, had a procedure complicated with in-stent thrombosis requiring thrombolysis and anticoagulation with improvement. The remaining two patients were medically treated because underlying thromboembolic disease (patient 4) and diffuse pulmonary vein stenosis not amenable to percutaneous intervention (patient 5).
CONCLUSIONS: Pulmonary vascular stenosis from external compression can be a rare but unrecognized caused of worsening symptoms in advanced sarcoidosis. Pulmonary vascular angioplasty and stenting can provide clinical benefit in select patients.

Entities:  

Keywords:  pulmonary stenting; sarcoidosis; vascular stenosis

Mesh:

Substances:

Year:  2016        PMID: 27758995

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  5 in total

Review 1.  Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?

Authors:  Jason Weatherald; Laurent Savale; Marc Humbert
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

2.  Sarcoidosis-associated Pulmonary Hypertension: Pathophysiology, Diagnosis, and Treatment.

Authors:  Heng Duong; Catherine A Bonham
Journal:  Clin Pulm Med       Date:  2018-03

3.  A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension.

Authors:  Maria Anna Bazmpani; Georgios Arsos; Paul Zarogoulidis; Argyrios Doumas; Theodoros Dimitroulas; George Sianos; Stavros Hadjimiltiades; Konstantinos Kouskouras; Eckhard Mayer; Haralambos Karvounis; George Giannakoulas
Journal:  Pulm Circ       Date:  2018-03-14       Impact factor: 3.017

Review 4.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25

5.  Management of Pulmonary Hypertension Due to Chronic Lung Disease.

Authors:  Jordan Sugarman; Jason Weatherald
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.